Onesource Specialty Pharma: Trading Window Closed for Q3 FY26 Results

OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) has announced the closure of its trading window for dealing in the company's shares. This closure is in accordance with the Secur...

OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) has announced the closure of its trading window for dealing in the company's shares. This closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prohibition of Insider Trading. The trading window will be shut from January 01, 2026. It will reopen 48 hours after the declaration of the financial results for the quarter and nine months ended December 31, 2025. The company will intimate the date of the Board Meeting, where these financial results will be declared, in due course.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Onesource Specialty Pharma Limited in the news today?

Onesource Specialty Pharma Limited (ONESOURCE) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any financial or operational performance information that would indicate a positive or negative sentiment.

Trading Window Disclosure
Onesource Specialty Pharma LimitedONESOURCEhttps://prysm.fi/v2/analyze/ONESOURCE

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Onesource Specialty Pharma: Trading Window Closed for Q3 FY26 Results

December 24, 2025, 07:40 AM

AI Sentiment Analysis

Top Queries to Ask About Onesource Specialty Pharma Limited

OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) has announced the closure of its trading window for dealing in the company's shares. This closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prohibition of Insider Trading.

The trading window will be shut from January 01, 2026. It will reopen 48 hours after the declaration of the financial results for the quarter and nine months ended December 31, 2025.

The company will intimate the date of the Board Meeting, where these financial results will be declared, in due course.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Onesource Specialty Pharma Limited

Discover more trending news on Prysm

View All